Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification

Published:2023-11 Issue: Volume:62 Page:101078
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Li Yun,Wang Na,Zhang Xiaoying,Cao Yang,Zhang Lingfeng,Liu Aiguo,Zhang Yicheng

Funder

National Natural Science Foundation of China

National High-tech Research and Development Program

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference88 articles.

1. Allogeneic stem cell transplantation: a historical and scientific overview;Singh;Cancer Res,2016

2. Pathophysiology of chronic graft-versus-host disease and therapeutic targets;Zeiser;N Engl J Med,2017

3. Acute graft-versus-host disease - biologic process, prevention, and therapy;Zeiser;N Engl J Med,2017

4. GVHD prophylaxis 2020;Gooptu;Front Immunol,2021

5. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective Study;Transplantation and Cellular Therapy;2024-08

2. Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation;Frontiers in Immunology;2024-06-06

3. Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice;International Journal of Molecular Sciences;2024-02-01

4. Research Progress on Hematopoietic Stem Cell Transplantation in the Treatment of Severe Aplastic Anemia;Advances in Clinical Medicine;2024

5. GVHD: better safe than sorry;Blood;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3